SCOPUS 정보 검색 플랫폼

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 4, 2001, Pages 583-586

Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole

(4) Mosquera, J a Warn, P A a Rodriguez Tudela, J L b Denning, D W a,c

a HOPE HOSPITAL (United Kingdom)

b INSTITUTO DE SALUD CARLOS III (Spain)

c NORTH MANCHESTER GENERAL HOSPITAL (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; HYDROXYITRACONAZOLE; ITRACONAZOLE;

ABSIDIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG ACTIVITY; IN VIVO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; MYCOSIS; NEUTROPENIA; NONHUMAN;

EID: 0034752671 PISSN: 03057453 EISSN: None Source Type: Journal
DOI: 10.1093/jac/48.4.583 Document Type: Article

Times cited : (20)

References (11)

1
- 0023110922
- Opportunistic zygomycotic infections
- (1987) Mycopathologia , vol.97 , pp. 33-41
- Espinel-Ingroff, A.¹ Oakley, L.A.² Kerkering, T.M.³

2
- 0024396083
- Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B
- (1989) Chemotherapy , vol.35 , pp. 267-272
- Van Cutsem, J.¹ Van Gerven, F.² Fransen, J.³ Janssen, P.A.J.⁴

3
- 84961038581
- Treatment of experimental mucormycosis (Rhizopus oryzae infection) in rabbits with amphotericin B
- (1958) Antibiotics and Chemotherapy , vol.8 , pp. 394-399
- Chick, E.W.¹ Evans, J.² Baker, R.D.³

4
- 0026872671
- Susceptibility of clinical isolates of fungi to saperconazole
- (1992) Mycopathologia , vol.118 , pp. 179-183
- Otčenášek, M.¹

5
- 0028694510
- In vitro susceptibility to 9 antifungal agents of 14 strains of Zygomycetes isolated from clinical specimens
- (1994) Mycopathologia , vol.128 , pp. 135-137
- Otčenášek, M.¹ Buchta, V.²

6
- 0023173133
- Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: Animal models
- (1987) Reviews of Infectious Diseases , vol.9 , Issue.SUPPL. 1 , pp. 15-32
- Van Cutsem, J.¹ Van Gerven, F.² Janssen, P.A.J.³

7
- 0031893541
- Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models
- (1998) Antimicrobial Agents and Chemotherapy , vol.42 , pp. 282-288
- Odds, F.C.¹ Van Gerven, F.² Espinel-Ingroff, A.³ Bartlett, M.S.⁴ Ghannoum, M.A.⁵ Lancaster, M.V.⁶

8
- 0033946315
- Combination antifungal therapy in treatment of murine pulmonary mucormycosis: Roles of quinolones and azoles
- (2000) Antimicrobial Agents and Chemotherapy , vol.44 , pp. 2004-2006
- Sugar, A.M.¹ Liu, X.-P.²

9
- 0033978008
- Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection
- (2000) Journal of Antimicrobial Chemotherapy , vol.45 , pp. 85-93
- Johnson, E.M.¹ Oakley, K.L.² Radford, S.A.³ Moore, C.⁴ Warn, P.⁵ Warnock, D.W.⁶

10
- 0028275659
- A new bioassay for serum itraconazole concentrations using hydroxyitraconazole standards
- (1994) Antimicrobial Agents and Chemotherapy , vol.38 , pp. 1561-1566
- Law, D.¹ Moore, C.B.² Denning, D.W.³

11
- 0028213287
- Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug
- (1994) Journal of Antimicrobial Chemotherapy , vol.33 , pp. 369-372
- Goldani, L.Z.¹ Sugar, A.M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.